|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
52533845
Online Users :
851
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"lin c y"
Showing items 521-530 of 2768 (277 Page(s) Totally)
<< < 48 49 50 51 52 53 54 55 56 57 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-27T05:32:39Z |
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019–2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
|
Tsai H.-Y.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Ko W.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Liao C.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017–2020
|
Lee Y.-L.; Ko W.-C.; Lee W.-S.; Lu P.-L.; Chen Y.-H.; Cheng S.-H.; Lu M.-C.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Shao P.-L.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Lin C.-N.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Tang H.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-27T05:32:37Z |
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020
|
Chien Y.-C.; Lee Y.-L.; Liu P.-Y.; Lu M.-C.; Shao P.-L.; Lu P.-L.; Cheng S.-H.; Lin C.-Y.; Wu T.-S.; Yen M.-Y.; Wang L.-S.; Liu C.-P.; Lee W.-S.; Shi Z.-Y.; Chen Y.-S.; Wang F.-D.; Tseng S.-H.; Chen Y.-H.; WANG-HUEI SHENG; Lee C.-M.; Chen Y.-H.; Ko W.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T05:40:33Z |
24-Hour Ambulatory Blood Pressure after Adenotonsillectomy in Childhood Sleep Apnea
|
Hsu W.-C.; Kang K.-T.; SHUENN-NAN CHIU; Weng W.-C.; Lee P.-L.; Lin C.-Y. |
| 臺大學術典藏 |
2021-09-17T05:40:31Z |
Effect of Adenotonsillectomy on Ambulatory Blood Pressure in Pediatric Obstructive Sleep Apnea: 6-Month Follow-up Study
|
Kang K.-T.; SHUENN-NAN CHIU; Lin C.-Y.; Weng W.-C.; Lee P.-L.; Hsu W.-C. |
| 臺大學術典藏 |
2021-09-17T05:40:30Z |
Trajectory of ambulatory blood pressure after adenotonsillectomy in children with obstructive sleep apnea: comparison at three- and six-month follow-up
|
Kang K.-T.; SHUENN-NAN CHIU; Lin C.-Y.; Weng W.-C.; Lee P.-L.; Hsu W.-C. |
| 臺大學術典藏 |
2021-09-09T07:52:51Z |
Identification of fibrillin-1 gene mutations in Marfan syndrome by high-resolution melting analysis
|
Hung C.-C.; Lin S.-Y.; Lee C.-N.; Cheng H.-Y.; Lin C.-Y.; Chang C.-H.; Chiu H.-H.; CHIH-CHIEH YU; Lin S.-P.; Cheng W.-F.; Ho H.-N.; Niu D.-M.; Su Y.-N. |
| 臺大學術典藏 |
2021-09-09T07:52:50Z |
Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome
|
Hung C.-C.; Lin S.-Y.; Lee C.-N.; Cheng H.-Y.; Lin S.-P.; Chen M.-R.; Chen C.-P.; Chang C.-H.; Lin C.-Y.; CHIH-CHIEH YU; Chiu H.-H.; Cheng W.-F.; Ho H.-N.; Niu D.-M.; Su Y. |
| 臺大學術典藏 |
2021-09-04T06:10:54Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; JIA-HORNG KAO; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; JIA-HORNG KAO; Yu M.-L.; Chuang W.-L.; Chen C.-J. |
| 臺大學術典藏 |
2021-09-04T05:16:55Z |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; JIA-HORNG KAO; Chuang W.-L.; Chen P.-J.; Chen D.-S. |
Showing items 521-530 of 2768 (277 Page(s) Totally)
<< < 48 49 50 51 52 53 54 55 56 57 > >>
View [10|25|50] records per page
|
